​

Funding Round

Series D - SQZ Biotech

Series D - SQZ Biotech

Investment Firm

Overview

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Announced Date

May 18, 2020

Closed on Date

May 18, 2020

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Temasek Holdings

Temasek Holdings

Temasek Holdings is a early_stage_venture and late_stage_venture and private_equity and secondary_market firm.

Participant Investors

8

Investor Name
Participant InvestorTemasek Holdings
Participant Investor+ND Capital
Participant InvestorInvus
Participant InvestorGoogle Ventures
Participant InvestorPolaris Partners

Round Details and Background

SQZ Biotech raised $65000000 on 2020-05-18 in Series D

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 30, 2016
Series B - SQZ Biotech
2-16.0M
Oct 29, 2014
Grant - SQZ Biotech
1-100.0K
Jun 24, 2015
Series A - SQZ Biotech
2-5.0M
Apr 07, 2014
Seed Round - SQZ Biotech
1-15.0K

Recent Activity

There is no recent news or activity for this profile.